DMCC Speciality Chemicals Limited (DMCC) AI Stock Analysis

• Market Cap: ₹5.80B
• Dividend Yield: 0.97%
• Average Volume (3M): 2.85K
• Price to Earnings (P/E): 20.8
• Beta (1Y): 0.47
• Revenue Growth: 40.79%
• EPS Growth: 109.95%
• Country: IN
• Employees: 418
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals
• EPS (TTM): 2.31
• Shares Outstanding: 24,939,932
• 10 Day Avg. Volume: 2,136
• 30 Day Avg. Volume: 2,850
• PEG Ratio: 0.40
• Price to Book (P/B): 3.25
• Price to Sales (P/S): 1.72
• P/FCF Ratio: 23.86
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 61 Neutral
• Price Target: ₹245.00 ▼(-2.74% Downside)

The overall stock score of 61 reflects a strong financial performance, which is the most significant factor. However, bearish technical indicators and a relatively high P/E ratio suggest caution. The lack of earnings call data and corporate events limits further insights.

Positive Factors

Revenue Growth Momentum

Sustained high revenue growth indicates durable demand and successful market penetration in specialty chemicals. Over the next 2–6 months this supports scale economies, reinvestment capacity and stronger bargaining leverage with suppliers and customers, underpinning medium-term operational expansion.

Strong Balance Sheet and Manageable Leverage

A favorable equity ratio and moderate leverage provide financial flexibility for capex, R&D and M&A without stressing liquidity. This balance reduces refinancing risk and supports consistent investment in product lines and capacity, bolstering resilience to cyclical downturns over months ahead.

Robust Operating Cash Flow and Conversion

Strong operating cash flow versus net income indicates solid cash-generating operations, enabling funding of working capital, capex and shareholder returns without relying on external financing. This cash conversion strength supports sustainable operations and strategic investments over the medium term.

Negative Factors

Volatile Free Cash Flow Growth

Inconsistent free cash flow growth raises concerns about funding predictability for capex, dividends and debt servicing. Over 2–6 months this volatility can limit flexibility for strategic investments, increase reliance on external funding, and amplify sensitivity to operational disruptions.

Fluctuating Net Profit Margins

Variable net margins suggest inconsistent cost control, pricing pressure or input volatility in specialty chemicals. Margin swings undermine earnings predictability and can erode return on capital, complicating budgeting and long-term investment decisions over the coming quarters.

Limited Investor Communication and Event Disclosure

Absence of earnings calls and notable corporate events reduces transparency on strategy, guidance and management intent. Over the medium term this makes it harder for investors to assess execution risk, monitor capital allocation and hold leadership accountable, raising governance uncertainty.

DMCC Speciality Chemicals Limited Business Overview & Revenue Model

Company Description

DMCC Speciality Chemicals Limited, together with its subsidiary, manufactures and sells specialty and commodity chemicals in India and internationally. The company offers sulphur, boron, functional, and life science chemicals. Its products are used in various applications in agro, construction, cosmetic, detergent, dye, electroplating, emulsion, fertilizer, fire retardant, ink, paper, pharmaceutical intermediate, pigment, polymer, textile processing, thermal paper coating, and water treatment markets. The company was formerly known as The Dharamsi Morarji Chemical Company Limited. DMCC Speciality Chemicals Limited was incorporated in 1919 and is headquartered in Mumbai, India.

How the Company Makes Money

DMCC generates revenue primarily through the sale of its specialty chemical products to various industries. The company's revenue model is based on direct sales to manufacturers and distributors, with a focus on long-term contracts that ensure a steady income stream. Key revenue streams include bulk sales of agrochemicals, specialty coatings, and advanced materials, which are often customized to meet client specifications. Additionally, DMCC has formed significant partnerships with research institutions and industry leaders to develop innovative chemical solutions, further enhancing its market position and driving growth. The company also benefits from economies of scale in production, allowing it to maintain competitive pricing while maximizing profit margins.

DMCC Speciality Chemicals Limited Financial Statement Overview

Summary

DMCC Speciality Chemicals Limited presents a strong financial profile with consistent revenue growth and solid profitability metrics. The balance sheet highlights financial stability with controlled leverage. Cash flow management appears effective, though there is room to stabilize free cash flow growth.

Income Statement

The income statement shows a solid gross profit margin with a consistent increase in total revenue over the years, indicating strong growth. However, the net profit margin fluctuated, showing some instability. The EBIT margin indicates adequate operational efficiency, while EBITDA margin supports good cash flow generation capability.

Balance Sheet

The balance sheet reflects a strong equity position, evident from a favorable equity ratio. The debt-to-equity ratio is moderate, suggesting manageable leverage. The company shows good return on equity, indicating effective use of shareholders' funds, despite some fluctuation in total liabilities.

Cash Flow

The cash flow statement indicates robust operating cash flow relative to net income, though free cash flow has seen some volatility. The free cash flow to net income ratio indicates good cash conversion, but the free cash flow growth rate has been inconsistent, highlighting potential investment risks.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	4.73B	4.31B	3.26B	3.85B	3.25B	1.96B
Gross Profit	1.48B	1.33B	1.14B	1.37B	1.28B	524.14M
EBITDA	662.59M	570.16M	366.94M	387.81M	467.11M	432.01M
Net Income	279.13M	215.28M	115.89M	69.31M	213.40M	325.79M
Balance Sheet
Total Assets	0.00	3.80B	3.77B	4.01B	3.84B	2.64B
Cash, Cash Equivalents and Short-Term Investments	60.40M	51.52M	70.63M	33.50M	29.59M	51.84M
Total Debt	0.00	470.70M	877.11M	1.01B	933.99M	350.80M
Total Liabilities	-2.28B	1.53B	1.68B	2.03B	1.90B	905.20M
Stockholders Equity	2.28B	2.28B	2.10B	1.98B	1.94B	1.73B
Cash Flow
Free Cash Flow	0.00	310.28M	194.33M	79.75M	-480.71M	-150.70M
Operating Cash Flow	0.00	380.41M	383.74M	298.81M	506.56M	322.45M
Investing Cash Flow	0.00	-66.82M	-100.42M	-205.59M	-984.14M	-396.61M
Financing Cash Flow	0.00	-297.83M	-271.01M	-99.94M	461.07M	30.22M

DMCC Speciality Chemicals Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 251.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DMCC, the sentiment is Negative. The current price of 251.9 is above the 20-day moving average (MA) of 229.65, above the 50-day MA of 247.53, and below the 200-day MA of 281.32, indicating a bearish trend. The MACD of -8.20 indicates Negative momentum. The RSI at 37.98 is Neutral, neither overbought nor oversold. The STOCH value of 70.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:DMCC.

DMCC Speciality Chemicals Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OCCL	72 Outperform	₹1.17B	10.38	―	10.99%	-76.65%	-76.77%
CHEMBOND	66 Neutral	₹1.98B	15.51	―	1.11%	-37.34%	-45.55%
INDOBORAX	63 Neutral	₹7.89B	17.17	―	0.38%	12.35%	6.79%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
DMCC	61 Neutral	₹5.80B	20.83	―	0.97%	40.79%	109.95%
CHEMCON	57 Neutral	₹6.53B	26.05	―	―	2.76%	30.68%
REGENCERAM	49 Neutral	₹1.17B	83.56	―	―	574.56%	―

DMCC Speciality Chemicals Limited Corporate Events

DMCC Speciality Chemicals Announces Trading Window Closure

DMCC Speciality Chemicals Limited announced the closure of its trading window from January 1, 2026, until 48 hours after the board meeting that will consider the unaudited financial results for the quarter and nine months ending December 31, 2025. This move is in compliance with SEBI’s insider trading regulations and aims to prevent insider trading by designated persons and their immediate relatives during this period.

DMCC Speciality Chemicals Releases Q2FY26 Earnings Call Transcript

DMCC Speciality Chemicals Limited announced the availability of the transcript from their Q2FY26 earnings conference call held with investors and analysts. This release provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its market positioning.

DMCC Speciality Chemicals Limited Releases Unaudited Financial Results for September 2025

DMCC Speciality Chemicals Limited announced its unaudited financial results for the quarter and half-year ending September 30, 2025. The results, published in The Free Press Journal and Navshakti, indicate the company’s financial performance and compliance with SEBI regulations. This announcement provides stakeholders with insights into the company’s operational efficiency and financial health, potentially impacting investor confidence and market positioning.